These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 447437)

  • 1. Plasma protein binding of salicylate and quinidine in patients with multiple myeloma.
    Perez-Mateo M; Erill S
    Int J Clin Pharmacol Biopharm; 1979 Apr; 17(4):168-70. PubMed ID: 447437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency.
    Pérez-Mateo M; Erill S
    Eur J Clin Pharmacol; 1977 Mar; 11(3):225-31. PubMed ID: 856605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood and saliva salicylate measurement in the monitoring of salicylate therapy.
    Pérez-Mateo M; Erill S; Cabezas R
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):113-5. PubMed ID: 844929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of plasma pH on quinidine uptake by erythrocytes: estimation of free drug fraction in plasma from blood/and erythrocyte/plasma concentration ratios.
    Ho Ngoc-Ta Trung A; Sirois G
    Pharm Acta Helv; 1987; 62(2):61-4. PubMed ID: 3575343
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in sodium salicylate protein binding in serum and synovial fluid from patients with a knee effusion.
    Caillier I; Bannwarth B; Monot C; Lapicque F; Netter P; Gaucher A; Royer RJ
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):7-13. PubMed ID: 2303312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum protein binding of salicylate during pregnancy and the puerperium.
    Lovecchio JL; Krasner J; Yaffe SJ
    Dev Pharmacol Ther; 1981; 2(3):172-9. PubMed ID: 7227142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of plasma protein binding on quinidine kinetics in the rabbit.
    Guentert TW; Oie S
    J Pharmacol Exp Ther; 1980 Oct; 215(1):165-71. PubMed ID: 7452481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Plasma protein binding of 3-(S) or 3-(R) hydroxylated derivatives of quinidine and dihydroquinidine].
    Leroyer R; Varoquaux O; Guillebastres R; Jarreau C; Normand JP; Jaillon P; Advenier C; Pays M
    Therapie; 1986; 41(3):159-62. PubMed ID: 3750253
    [No Abstract]   [Full Text] [Related]  

  • 9. Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operations.
    Davies RF; Dubé LM; Mousseau N; McGilveray I; Beanlands DS
    J Thorac Cardiovasc Surg; 1988 Oct; 96(4):634-41. PubMed ID: 3172810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro studies on the binding of salicylate to human plasma proteins: evidence for one type of binding site.
    Cham BE; Bochner F; Imhoff DM; Byrne G; Gunsberg M
    J Pharmacol Exp Ther; 1982 Mar; 220(3):648-53. PubMed ID: 7062274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Protein binding of salicylates in rheumatoid arthritis].
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Pourel J; Faure G; Martin J; Gaucher A
    Rev Rhum Mal Osteoartic; 1982 May; 49(6):447-52. PubMed ID: 7112023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma protein carbamylation and decreased acidic drug protein binding in uremia.
    Erill S; Calvo R; Carlos R
    Clin Pharmacol Ther; 1980 May; 27(5):612-8. PubMed ID: 7371359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid fluorometric analysis of unbound salicylate in whole blood.
    Baselt RC; Stewart CB
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):351-60. PubMed ID: 981790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood binding of selezen (imidazole salicylate) in man.
    Zini R; Morin D; Acuto GC; Bianchini C; de Santis F; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):242-9. PubMed ID: 1869346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of a plasma salicylate assay service in a medical unit in Hong Kong: a follow-up study.
    Chan TY; Chan AY
    Vet Hum Toxicol; 1996 Aug; 38(4):278-9. PubMed ID: 8829346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma electrolytes in multiple myeloma].
    Miseta A; Kellermayer M; Liszt F; Ludány A; Magyarlaki T; Sipos K; Berkó G; Tókés-Fúzesi M
    Orv Hetil; 2001 Jul; 142(27):1449-53. PubMed ID: 11481908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein binding of salicylate in uremic and normal plasma.
    Borgå O; Cederlöf IO; Ringberger VA; Norlin A
    Clin Pharmacol Ther; 1976 Oct; 20(4):464-75. PubMed ID: 975718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction for plasma protein binding: physostigmine and other drugs.
    Somani SM; Unni LK; McFadden DL
    Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):412-6. PubMed ID: 3654032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The pattern of response to chemotherapy and prognosis in patients with multiple myeloma].
    Murakami H; Yanagisawa T; Tukamoto N; Kurabayashi H; Tamura J; Katahira H; Morita K; Sawamura M; Karasawa M; Nemoto K
    Rinsho Ketsueki; 1988 Nov; 29(11):2004-10. PubMed ID: 3236410
    [No Abstract]   [Full Text] [Related]  

  • 20. Multiple myeloma with discordant M components in the serum and CSF.
    Dotten DA; Pruzanski W
    Arch Intern Med; 1981 Sep; 141(10):1374-6. PubMed ID: 6791605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.